Interdigitated Bio-impedimetric Device for Point-of-Care Assessment of Blood Coagulation

AFFILIATION:   Independent Startup (C-Corporation), Hollister, California, United States


Track: Energy & Resilience
Area: Soldier Technologies
Tech Readiness: TRL 4

Tech Brief: This is a diagnostic technology which provides point-of-care assessments on how a person’s blood coagulation is proceeding. This device relies on electrical conductivity sensing of blood samples to determine coagulation processes; as blood coagulates, measurable changes in conductivity can be measured with a uniquely patterned sensor electrode, circuitry, and software.


Value Proposition: For the last decade of continuous war, 75% of casualties are associated with explosive and gunshot related injuries. Improved trauma intervention has dramatically improved survivability, yet some soldiers die before reaching a medical treatment facility that provides such intervention. It has been estimated that 24.3% of these deaths are potentially savable. The vast majority of these deaths are associated with hemorrhage (90.9%), and so there is a dire need for diagnostic hemorrhage treating devices that be deployed outside of a medical treatment facility. We believe our device will save lives by making medicine more personalized. This meet one of NAE Grand Challenges for Engineering: engineer of better medicines. We predict that our device will reduce trial-and-error treatments and allow optimum doses to be administered sooner. By meeting stringent military requirements, we believe that our device will also meet the requirements of civilian hospitals and EMT responders, strengthening healthcare and diagnostics across the nation.


Org Type: Early-stage Startup (Seed)
Website: *Incorporation